Our research focuses on improving the outcomes of children with cancer

Press Office

Susanne Barkmann

Phone+49 (0)40-426051212
Mobile+49 (0)173-6276993


Fetal microchimerism is associated with better outcome in pediatric leukemia patients.

The team of the project better world (PBW) earned 800 Euro at this year’s sale from stock for the benefit of children’s cancer research.

Prof. Dr. Martin Horstmann under discussion with Carsten Schröder about the possibility to create new leukemia therapies out of research results.

The prestigious Research Prize 2014 of the Cancer Society Hamburg has been awarded to Prof. Dr. Martin Horstmann, Scientific Director of the Research Institute of the Children's Cancer Center Hamburg (full text in German only).

The funded research project aims to precisely decode the molecular modes of action of ZNF423 in the formation of leukaemia and thus contribute to the development of more targeted and gentler treatment strategies.

Grant received: Erich & Gertrud Roggenbuck-Stiftung supports the project "signal transduction" with totally 48.700 Euro

Prof. Dr. Martin Horstmann ist zum Editor von Pediatric Research für die Sektion Hematology and Oncology ernannt worden.

Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia

Das Gedränge war groß in der 5. Nacht des Wissens in Hamburg. Über 29.000 Besucher waren unterwegs, fast 50 % mehr als 2011.

Wir präsentieren uns am 2. November 2013 im UKE Campus Lehre und im Wissenschaftszelt am Jungfernstieg.